These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23806453)

  • 1. The mountain cedar model in clinical trials of seasonal allergic rhinoconjunctivitis.
    Andrews CP; Ratner PH; Ehler BR; Brooks EG; Pollock BH; Ramirez DA; Jacobs RL
    Ann Allergy Asthma Immunol; 2013 Jul; 111(1):9-13. PubMed ID: 23806453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cockroach sensitization mitigates allergic rhinoconjunctivitis symptom severity in patients allergic to house dust mites and pollen.
    He W; Jimenez F; Martinez H; Harper NL; Manoharan MS; Carrillo A; Ingale P; Liu YG; Ahuja SS; Clark RA; Rather CG; Ramirez DA; Andrews CP; Jacobs RL; Ahuja SK
    J Allergy Clin Immunol; 2015 Sep; 136(3):658-66. PubMed ID: 26026342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relevance of patient-reported outcomes in a grass pollen immunotherapy trial in children and adolescents with rhinoconjunctivitis.
    Röder E; Berger MY; Hop WC; de Groot H; van Wijk RG
    Pediatr Allergy Immunol; 2013 Feb; 24(1):39-48. PubMed ID: 22882319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of confounding cofactors on responses to pollens during natural season versus pollen challenge chamber exposure.
    Jacobs RL; Harper N; He W; Andrews CP; Rather CG; Ramirez DA; Ahuja SK
    J Allergy Clin Immunol; 2014 May; 133(5):1340-6, 1346.e1-7. PubMed ID: 24331377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
    Hordijk GJ; Antvelink JB; Luwema RA
    Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
    Wolthers OD; Høst A; Frederiksen B; Halken S
    Ugeskr Laeger; 2012 Aug; 174(35):1989-92. PubMed ID: 22929576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy with an aluminum hydroxide-adsorbed Juniperus ashei foreign pollen extract in seasonal indigenous cypress pollen rhinoconjunctivitis. A double-blind, placebo-controlled study.
    Charpin D; Gouitaa M; Dron-Gonzalvez M; Fardeau MF; Massabie-Bouchat YP; Hugues B; Fabre C; Vivinus S; Pegliasco H; André C
    Int Arch Allergy Immunol; 2007; 143(2):83-91. PubMed ID: 17228169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes.
    Jacobs RL; Harper N; He W; Andrews CP; Rather CG; Ramirez DA; Ahuja SK
    J Allergy Clin Immunol; 2012 Jul; 130(1):122-7.e8. PubMed ID: 22554707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralymphatic immunotherapy for mountain cedar pollinosis: A randomized, double-blind, placebo-controlled trial.
    Thompson CP; Silvers S; Shapiro MA
    Ann Allergy Asthma Immunol; 2020 Sep; 125(3):311-318.e2. PubMed ID: 32407947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet.
    Nelson H; Lehmann L; Blaiss MS
    Curr Med Res Opin; 2012 Jun; 28(6):1043-51. PubMed ID: 22502864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the biogenics research chamber for Juniperus ashei (mountain cedar) pollen.
    Jacobs RL; Ramirez DA; Andrews CP
    Ann Allergy Asthma Immunol; 2011 Aug; 107(2):133-8. PubMed ID: 21802021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
    Rak S; Heinrich C; Scheynius A
    Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic reactions to immunotherapy during mountain cedar season: implications for seasonal dose adjustment.
    Wong PH; Quinn JM; Gomez RA; Webb CN
    J Allergy Clin Immunol Pract; 2017; 5(5):1438-1439.e1. PubMed ID: 28499782
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral immunotherapy in oculorhinitis from Gramineae].
    Pacor ML; Biasi D; Carletto A; Maleknia T; Lunardi C
    Recenti Prog Med; 1996 Jan; 87(1):4-6. PubMed ID: 8711254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
    Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.